Claire Bouleti
Distinguished in Mitral Stenosis

Claire Bouleti

Poitiers, FR 
Distinguished in Mitral Stenosis
Poitiers, FR 
OverviewLocationsClinical Research

Overview

Claire Bouleti practices in Poitiers, France. Ms. Bouleti is rated as a Distinguished expert by MediFind in the treatment of Mitral Stenosis. Her top areas of expertise are Mitral Stenosis, Myocarditis, Marfan Syndrome, Transcatheter Aortic Valve Replacement (TAVR), and Percutaneous Coronary Intervention (PCI).

Her clinical research consists of co-authoring 106 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 1 clinical trial in the study of Mitral Stenosis.

Gender
Female

Locations

Poitiers, France
Other Locations
Paris, 75000, France
Toulouse, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction, a Phase II, Multicenter, Randomized, Double Blinded, Placebo Controlled Clinical Trial
COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction, a Phase II, Multicenter, Randomized, Double Blinded, Placebo Controlled Clinical Trial
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: Colchicine Group 
Study Phase: Phase 2
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
Myocardial Ischemia and Transfusion
Myocardial Ischemia and Transfusion
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Biological
Study Phase: Phase 3
French National Observatory of Percutaneous Mitral Commissurotomy (PMC) Immediate Score, Scanner, Late Results
French National Observatory of Percutaneous Mitral Commissurotomy (PMC) Immediate Score, Scanner, Late Results
Enrollment Status: Completed
Publish Date: September 21, 2022
View 3 Less Clinical Trials

106 Total Publications

Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories.
Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories.
Journal: Gut
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bouleti's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile